{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:01:57Z","timestamp":1785589317642,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":83,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.schres.2023.10.040","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T10:40:20Z","timestamp":1700217620000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2699-8422","authenticated-orcid":false,"given":"Nazar","family":"Kuzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2524-7445","authenticated-orcid":false,"given":"Bohdan","family":"Blyzniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-8460","authenticated-orcid":false,"given":"Egor","family":"Chumakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7311-4426","authenticated-orcid":false,"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2314","authenticated-orcid":false,"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4117","authenticated-orcid":false,"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2023.10.040_bb0005","article-title":"[Analysis of neuroleptic prescription in patients with schizophrenia with using \u201cquality indicators\u201d in a psychiatric hospital] in Russian","volume":"17\u201321","author":"Altynbekov","year":"2017","journal-title":"Nevrologicheskij vestnik XLIX"},{"key":"10.1016\/j.schres.2023.10.040_bb0010","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2307\/4148594","article-title":"Soviet Empire as \u201cFamily Resemblance\u201d","volume":"65","author":"Beissinger","year":"2006","journal-title":"Slav. Rev."},{"key":"10.1016\/j.schres.2023.10.040_bb0015","first-page":"401","article-title":"[Clinico-pharmacokinetic prediction of the efficacy of treatment: the test dose] in Russian","volume":"84","author":"Beliaev","year":"1984","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0020","first-page":"61","article-title":"Glutamine synthetase-like protein, glutamate dehydrogenase, and cytochrome c-oxidase in platelets of patients with the first episode psychosis in the course of treatment","volume":"111","author":"Burbaeva","year":"2011","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2307\/20031013","article-title":"Soviet colonialism in Central Asia","volume":"32","author":"Caroe","year":"1953","journal-title":"Foreign Aff."},{"key":"10.1016\/j.schres.2023.10.040_bb0030","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.schres.2023.10.040_bb0035","first-page":"85","article-title":"[Differentiated use of atypical antipsychotics in patients with schizophrenia during its exacerbation (results of a comparative study)] in Russian","volume":"62","author":"Danilov","year":"2010","journal-title":"Sibirskij vestnik psihiatrii i narkologii"},{"key":"10.1016\/j.schres.2023.10.040_bb0040","first-page":"82","article-title":"[Therapy of exacerbations of continuous paranoid schizophrenia (efficacy of clozapine, risperidone, olanzapine, quetiapine and typical antipsychotics and its dependence on the clinical features of the disease)] in Russian","volume":"60","author":"Danilov","year":"2010","journal-title":"Sibirskij vestnik psihiatrii i narkologii"},{"key":"10.1016\/j.schres.2023.10.040_bb0045","first-page":"80","article-title":"[Differentiated use of atypical antipsychotics in patients with schizophrenia during its remission (results of a comparative study)] in Russian","volume":"63","author":"Danilov","year":"2010","journal-title":"Sibirskij vestnik psihiatrii i narkologii"},{"key":"10.1016\/j.schres.2023.10.040_bb0050","first-page":"34","article-title":"[The use of aripiprazole in the treatment of obesity associated with the administration of neuroleptics of the second generation in patients with schizophrenia] in Russian","volume":"114","author":"Danilov","year":"2014","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0055","first-page":"23","article-title":"[Transition experience from clozapine to aripiprazole with patients having intermittent schizophrenia within the period of therapeutic remission] in Russian","volume":"6","author":"Danilov","year":"2013","journal-title":"Psihiatriya Psihiatriya i psihofarmakoterapiya im. P.B Gannushkina"},{"key":"10.1016\/j.schres.2023.10.040_bb0060","first-page":"25","article-title":"[Prescription of traditional neuroleptics in the remission period for schizophrenic patients with excess of body mass caused by atypical antipsychotics] in Russian","volume":"107","author":"Danilov","year":"2007","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb5000","series-title":"GEOTAR-Media","article-title":"[Psychiatry: national guideline] in Russian","author":"Dmitrieva","year":"2009"},{"key":"10.1016\/j.schres.2023.10.040_bb0065","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.040_bb0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.rpsm.2021.09.001","article-title":"Clozapine-induced myocarditis in Russia: animal studies but no clinical studies","volume":"15","author":"Kirilochev","year":"2022","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.schres.2023.10.040_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.09.020","article-title":"A scoping review of literature on clozapine from former USSR states published in Russian language","author":"Kirilochev","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.040_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/hm.hm_73_19","article-title":"Treatment patterns of patients with schizophrenia based on the data from 44,836 outpatients in Russia","volume":"3","author":"Kostev","year":"2019","journal-title":"Heart and Mind"},{"key":"10.1016\/j.schres.2023.10.040_bb0085","series-title":"After the Wall Fell: The Poor Balance Sheet of the Transition to Capitalism","first-page":"135","volume":"58","author":"Milanovic","year":"2015"},{"key":"10.1016\/j.schres.2023.10.040_bb0090","first-page":"11","article-title":"[\u0421linical predictors of the effectiveness of electroconvulsive therapy in therapeutically resistant schizophrenia] in Russian","volume":"2","author":"Oleneva","year":"2021","journal-title":"Sovremennaya terapiya psihicheskih rasstro\u012dstv"},{"key":"10.1016\/j.schres.2023.10.040_bb0095","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2023.10.040_bb0100","first-page":"1247","article-title":"[Long-term treatment of schizophrenic patients with leponex (clozapine)] in Russian","volume":"78","author":"Panteleeva","year":"1978","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0105","first-page":"70","article-title":"[Problem of side effects of leponex on blood (multicenter inter- national study)] in Russian","volume":"91","author":"Panteleeva","year":"1991","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0110","first-page":"73","article-title":"[Wide individual variability in antipsychotic concentrations in patients with exacerbation of schizophrenia in routine practice] in Russian","volume":"27","author":"Potanin","year":"2017","journal-title":"Social\u2019naya i klinicheskaya psihiatriya"},{"key":"10.1016\/j.schres.2023.10.040_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.09.002","article-title":"An expert review of clozapine in Eastern European countries: use, regulations and pharmacovigilance","author":"Sagud","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.040_bb0120","first-page":"54","article-title":"[Results of a clinical study of a new form of atypical antipsychotic Azaleptin\u00ae retard] in Russian","volume":"31","author":"Schastnyj","year":"2021","journal-title":"Social\u2019naya i klinicheskaya psihiatriya"},{"key":"10.1016\/j.schres.2023.10.040_bb0125","first-page":"40","article-title":"[Main trends in the demographic development in Russia and dynamics of the rate of patients with schizophrenia] in Russian","volume":"98","author":"Se\u012dku","year":"1998","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0130","first-page":"24","article-title":"[Approaches to the improvement of treatment efficacy in patients with acute severe asaleptin intoxication complicated by acute respiratory insufficiency of mixed genesis] in Russian","volume":"90","author":"Shilov","year":"2012","journal-title":"Klin Med (Mosk)"},{"key":"10.1016\/j.schres.2023.10.040_bb0135","first-page":"43","article-title":"[Features of clinical course and the experience using of reamberin in complex intensive therapy in patients with acute severe azaleptin poisonings] in Russian","author":"Shilov","year":"2012","journal-title":"Georgian Med. News"},{"key":"10.1016\/j.schres.2023.10.040_bb0140","first-page":"28","article-title":"Pharmacological correction of the effectiveness of plasmapheresis using the infusion antihypoxant cytoflavin\u00a9 in acute poisoning with azaleptin","volume":"138","author":"Shilov","year":"2016","journal-title":"Toksikologicheskij vestnik"},{"key":"10.1016\/j.schres.2023.10.040_bb0145","first-page":"518","article-title":"[Pharmacological correction of hyperammonemia in criminal poisoning with clozapine] in Russian","volume":"11","author":"Slyundin","year":"2010","journal-title":"Medline.ru. Rossijskij biomedicinskij zhurnal"},{"key":"10.1016\/j.schres.2023.10.040_bb0150","first-page":"888","article-title":"[Psychotropic drug therapy using maintenance dosage pumps] in Russian","volume":"87","author":"Smulevich","year":"1987","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0155","author":"State Register of Medicines of the Russian Federation"},{"key":"10.1016\/j.schres.2023.10.040_bb0160","series-title":"The Cost of Mental Health in Ukraine: The Review of Privately and Publicly Procured Medicines and Dietary Supplements (2015\u20132019)","author":"Sukhovii","year":"2022"},{"key":"10.1016\/j.schres.2023.10.040_bb0165","first-page":"37","article-title":"[Clozapine is the drug of choice for the treatment of patients with acute psychosis] in Russian","volume":"21","author":"Tochilov","year":"2011","journal-title":"Social\u2019naya i klinicheskaya psihiatriya"},{"key":"10.1016\/j.schres.2023.10.040_bb0170","first-page":"1217","article-title":"[Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics] in Russian","volume":"86","author":"Vasil\u2019ev","year":"1986","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.schres.2023.10.040_bb0175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.17749\/2070-4909\/farmakoekonomika.2020.053","article-title":"[Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up] in Russian","volume":"13","author":"Vaskova","year":"2020","journal-title":"FARMAKOEKONOMIKA. Modern Pharmacoecon. Pharmacoepidemiol."},{"key":"10.1016\/j.schres.2023.10.040_bb0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/ps.46.3.256","article-title":"Clozapine treatment in Russia: a review of clinical research","volume":"46","author":"Wolf","year":"1995","journal-title":"Psychiatr. Serv."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423004024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423004024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:15:31Z","timestamp":1730520931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423004024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":37,"alternative-id":["S0920996423004024"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.10.040","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}